John Patrick Shannon Jr - Chief Executive Officer and Director, Director at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer and Director, Director
Issuer Symbol
XERS on Nasdaq
All Insider Reports
All Insider Reports

John Patrick Shannon Jr - trading volume in the past year for Xeris Biopharma Holdings, Inc.

Holdings reported by John Patrick Shannon Jr for Xeris Biopharma Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,935,578 $21,605,854 $7.36 31 Jan 2026 Direct
Stock Option (Right to Buy) 639,639 30 Jan 2026 Direct Common Stock
Stock Appreciation Right 600,000 31 Jan 2025 Direct Common Stock

Transactions reported by John Patrick Shannon Jr for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.